Insider · CIK 0001343266
Richard W Pascoe
Files at SEEL (SEELOS THERAPEUTICS, INC.). First filing -, latest -.
In brief
Richard W Pascoe files SEC Form 4 as director at SEEL (SEELOS THERAPEUTICS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Richard W Pascoe has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 4, 2024 | SEEL SEELOS THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +1,666 | $0.00 | $0 | 1,666 | Jan 8, 2024 |
Questions about Richard W Pascoe
Answered from the filings on this page, as of the latest one.
Is Richard W Pascoe buying or selling?
Richard W Pascoe has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Richard W Pascoe's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Richard W Pascoe has 0.
Where does Richard W Pascoe file Form 4?
Richard W Pascoe has filed Form 4 at SEEL (SEELOS THERAPEUTICS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.